Total Equity - NuVasive Inc (F:NK8) - Alpha Spread
N

NuVasive Inc
F:NK8

Watchlist Manager
NuVasive Inc
F:NK8
Watchlist
Price: 36.8 EUR Market Closed
Market Cap: 1.9B EUR
Have any thoughts about
NuVasive Inc?
Write Note

NuVasive Inc
Total Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

NuVasive Inc
Total Equity Peer Comparison

Comparables:
BDX
BSX
SYK
ABT
ISRG

Competitive Total Equity Analysis
Latest Figures & CAGR of Competitors

Company Total Equity CAGR 3Y CAGR 5Y CAGR 10Y
N
NuVasive Inc
F:NK8
Total Equity
$892.5m
CAGR 3-Years
0%
CAGR 5-Years
3%
CAGR 10-Years
5%
Becton Dickinson and Co
NYSE:BDX
Total Equity
$25.9B
CAGR 3-Years
2%
CAGR 5-Years
4%
CAGR 10-Years
17%
Boston Scientific Corp
NYSE:BSX
Total Equity
$20.4B
CAGR 3-Years
9%
CAGR 5-Years
17%
CAGR 10-Years
12%
Stryker Corp
NYSE:SYK
Total Equity
$19.8B
CAGR 3-Years
13%
CAGR 5-Years
11%
CAGR 10-Years
8%
Abbott Laboratories
NYSE:ABT
Total Equity
$39.3B
CAGR 3-Years
5%
CAGR 5-Years
4%
CAGR 10-Years
5%
Intuitive Surgical Inc
NASDAQ:ISRG
Total Equity
$14.7B
CAGR 3-Years
11%
CAGR 5-Years
15%
CAGR 10-Years
18%

See Also

What is NuVasive Inc's Total Equity?
Total Equity
892.5m USD

Based on the financial report for Jun 30, 2023, NuVasive Inc's Total Equity amounts to 892.5m USD.

What is NuVasive Inc's Total Equity growth rate?
Total Equity CAGR 10Y
5%

Over the last year, the Total Equity growth was 8%.

Back to Top